Analystreport

Seelos Therapeutics, Inc. (NASDAQ: SEEL) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.

Seelos Therapeutics, Inc.  (SEEL) 
Last seelos therapeutics, inc. earnings: 5/21 05:12 pm Check Earnings Report